Currently out of the existing stock ratings of Joshua Raskin, 1 are a SELL (3.13%), 23 are a BUY (71.88%), 8 are a HOLD (25%).
Analyst Joshua Raskin, has had 75% of price targets met with an average potential upside of 14.3%, reached in 179 days on average. Previously, Joshua Raskin worked at BARCLAYS, NEPHRON RESEARCH.
Joshua Raskin has documented 75 price targets and ratings displayed on 6 stocks. The coverage was on Healthcare, Industrials sectors.
Most recent stock forecast was given on WLK, Westlake Chemical at 21-Feb-2025.
Analyst best performing recommendations are on MOH (MOLINA HEALTHCARE).
The best stock recommendation documented was for MOH (MOLINA HEALTHCARE) on 1/5/2012. The price target of $26 was fulfilled within 4 days with a profit of $2.12 (8.88%), with a performance score of 22.19.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Dec-2018
$82
$10.73 (15.06%)
$78
13 days ago
(02-Nov-2026)
13/21 (61.9%)
$15.47 (23.25%)
395
Hold Since 07-Oct-2025
$75
$3.73 (5.23%)
$69
16 days ago
(30-Oct-2026)
18/28 (64.29%)
$6.55 (9.57%)
177
Hold Since 29-Jul-2025
$75
$3.73 (5.23%)
$67
17 days ago
(29-Oct-2026)
8/9 (88.89%)
$6.38 (9.30%)
138
Hold Since 30-May-2024
$71
$-0.27 (-0.38%)
$66
18 days ago
(28-Oct-2026)
4/5 (80%)
$2.29 (3.33%)
281
Buy Since 21-May-2026
$82
$10.73 (15.06%)
$74
18 days ago
(28-Oct-2026)
10/12 (83.33%)
$13.29 (19.34%)
188
